enzymatic-dna-synthesis
(3)
DNA Script
DNA Script is a French life-sciences technology company that pioneered Enzymatic DNA Synthesis (EDS) and built the SYNTAX System, the first benchtop DNA printer that lets researchers make custom DNA oligonucleotides on-site in hours instead of waiting days for outsourced orders. Founded in 2014 in Le Kremlin-Bicetre near Paris, the company aims to make biology programmable by putting rapid, template-free DNA production directly on the lab bench.
Ansa Biotechnologies, Inc.
Ansa Biotechnologies is an Emeryville, California biotech company that makes custom synthetic DNA using a proprietary enzymatic synthesis platform. Its no-assembly approach can build long, complex, high-fidelity DNA sequences - including clonal constructs up to 50 kilobases - that stump legacy chemical methods, and it backs delivery with an industry-first On-Time Guarantee. Founded in 2018 by UC Berkeley researchers, Ansa serves scientists across pharmaceuticals, gene therapy, agriculture, and industrial biotech.
Marc Montserrat
Marc Montserrat is the Chief Executive Officer of DNA Script, a French-American biotech pioneering enzymatic DNA synthesis - a technology that lets labs print custom DNA on demand, in hours instead of days. A Wharton MBA and industrial engineer by training, Montserrat spent two decades building commercial operations at Ariosa Diagnostics (prenatal testing), Omniome (next-gen sequencing), and Deepcell (AI-powered single-cell analysis) before co-founding Splice Bio and ultimately landing as CEO of DNA Script in October 2024. He was drawn into life sciences after a misdiagnosis scare at 24 that convinced him life was too short to spend on work without meaning.